Genesystem Co., Ltd. (KOSDAQ: 363250)
South Korea
· Delayed Price · Currency is KRW 8,820.00
-230.00 (-2.54%)
Dec 19, 2024, 1:59 PM KST
Genesystem Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -11,266 | -8,996 | 3,551 | -2,224 | -4,041 |
| Depreciation & Amortization | 410.46 | 386.3 | 308.08 | 249.82 | 135.93 |
| Loss (Gain) From Sale of Assets | 3.14 | 3.14 | 0 | - | - |
| Loss (Gain) From Sale of Investments | -53.17 | 380.34 | 8.59 | - | - |
| Loss (Gain) on Equity Investments | 583.97 | 444.93 | - | - | - |
| Stock-Based Compensation | 106.87 | 80.15 | 80.3 | 321.2 | 240.9 |
| Provision & Write-off of Bad Debts | 224.75 | 303.51 | 39.81 | -37.24 | 207.45 |
| Other Operating Activities | 2,688 | 2,252 | -715.83 | 6,127 | 1,720 |
| Change in Accounts Receivable | 38.59 | 1,163 | -1,029 | -643.35 | -322.75 |
| Change in Inventory | -117.2 | -1,772 | -324.61 | -957.07 | -132.37 |
| Change in Accounts Payable | -68.58 | -259.43 | 37.31 | 163.26 | 58.87 |
| Change in Unearned Revenue | -51.91 | 35.02 | - | - | - |
| Change in Other Net Operating Assets | 114.11 | -438.07 | -969.97 | 697.26 | 40.61 |
| Operating Cash Flow | -7,365 | -6,417 | 985.71 | 3,697 | -2,093 |
| Operating Cash Flow Growth | - | - | -73.34% | - | - |
| Capital Expenditures | -166.72 | -238.43 | -323.95 | -5,741 | -136.54 |
| Sale (Purchase) of Intangibles | -64.66 | -86.86 | -474.29 | -41.68 | -161.57 |
| Investment in Securities | -3,556 | -2,260 | -12,120 | - | - |
| Other Investing Activities | 18.05 | 20.68 | 17.46 | 21.18 | 10.17 |
| Investing Cash Flow | -4,770 | -2,565 | -12,901 | -5,761 | -287.94 |
| Short-Term Debt Issued | - | - | 2,103 | 1,116 | - |
| Long-Term Debt Issued | - | - | - | 3,000 | - |
| Total Debt Issued | - | - | 2,103 | 4,116 | - |
| Short-Term Debt Repaid | - | - | -2,103 | -666.34 | - |
| Long-Term Debt Repaid | - | -71.34 | -37.45 | -7.14 | -39.22 |
| Total Debt Repaid | -76.93 | -71.34 | -2,141 | -673.48 | -39.22 |
| Net Debt Issued (Repaid) | -76.93 | -71.34 | -37.45 | 3,443 | -39.22 |
| Issuance of Common Stock | 179.33 | 224.33 | 29,655 | 1,601 | - |
| Other Financing Activities | 42.96 | 28.32 | -1,763 | 16.83 | 10 |
| Financing Cash Flow | 145.37 | 181.32 | 27,854 | 11,062 | -29.22 |
| Foreign Exchange Rate Adjustments | -67.13 | 6.32 | 633.99 | -741.67 | -0.73 |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | 0 | - |
| Net Cash Flow | -12,056 | -8,794 | 16,573 | 8,256 | -2,411 |
| Free Cash Flow | -7,532 | -6,655 | 661.76 | -2,044 | -2,229 |
| Free Cash Flow Margin | -480.80% | -182.18% | 5.00% | -15.42% | -196.43% |
| Free Cash Flow Per Share | -1085.38 | -964.32 | 103.23 | -540.36 | -1008.42 |
| Cash Interest Paid | 92.82 | 95.06 | 86.41 | 75.79 | 17.45 |
| Cash Income Tax Paid | 51.55 | 64.87 | 2.86 | -0.07 | 0.13 |
| Levered Free Cash Flow | -5,710 | -4,814 | -669.69 | -8,251 | - |
| Unlevered Free Cash Flow | -5,632 | -4,754 | -614.16 | -7,973 | - |
| Change in Net Working Capital | 261.09 | 767.36 | 1,621 | 4,864 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.